Skip to Main Navigation

Maldives COVID-19 Emergency Response and Health Systems Preparedness Project

Abstract*

As of March 16, 2020, the Maldives has already reported 13 confirmed cases of the novel coronavirus COVID-19, mostly among tourists. Three people are hospitalized with another 20 people quarantined in Villivaru and 12 in isolation at Farukolhu. With a high population density in Male and tourists from all over the world, it is crucial to effectively prevent, control and respond to public health emergencies in a timely manner. The government has been...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The proposed project development objective is to respond to and mitigate the threat posed by COVID-19 and strengthen national systems for public health preparedness in the Maldives.

Key Details

Project Details

  • P173801

  • Closed

  • Gyorgy Fritsche , Di Dong

  • Republic of Maldives

  • Maldives

  • March 23, 2020

  • (as of board presentation)

    April 2, 2020

  • April 4, 2020

  • US$ 14.60 million

  • Ministry of Health (MOH)

  • South Asia

  • 2020

  • US$ 14.60 million

  • N/A

  • Substantial

  • December 31, 2023

  • No

  • BANK APPROVED

  • December 10, 2023

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Asian Infrastructure Investment Bank 7.30
IDA Credit 3.65
IDA Grant 3.65

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 7.30
IBRD + IDA Commitment 7.30
Lending Instrument
Grant Amount 7.30
Total Project Cost** 14.60

Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of April 30, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Feb 15, 2024 IDA-65910 Int Charges 4.33
Feb 15, 2024 IDA-65910 Int Charges 4.33
Feb 15, 2024 IDA-65910 Int Charges 5,951.94
Aug 15, 2024 IDA-65910 Int Charges 62.81
Aug 15, 2024 IDA-65910 Int Charges 7,252.69
Aug 15, 2024 IDA-65910 Int Charges 7,252.69
Aug 15, 2024 IDA-65910 Int Charges 62.81
May 18, 2020 IDA-D5950 Loan Disb 142,218.34
Jun 24, 2020 IDA-D5950 Loan Disb 156,445.98
Jun 24, 2020 IDA-D5950 Loan Disb 143,526.05
Jun 16, 2020 IDA-D5950 Loan Disb 21,354.70
Jun 22, 2020 IDA-D5950 Loan Disb 64,840.38
May 6, 2020 IDA-D5950 Loan Disb 102,255.00
Jul 14, 2020 IDA-D5950 Loan Disb 47,902.80
Sep 28, 2020 IDA-D5950 Loan Disb 501,467.62
Aug 17, 2020 IDA-65910 Loan Disb 476,129.03
Oct 26, 2020 IDA-D5950 Loan Disb 466,992.66
Nov 3, 2020 IDA-D5950 Loan Disb 35,316.00
Oct 29, 2021 IDA-D5950 Loan Disb 80,283.81
Oct 21, 2021 IDA-D5950 Loan Disb 79,350.00
Nov 9, 2021 IDA-D5950 Loan Disb 201,911.70
May 20, 2022 IDA-D5950 Loan Disb 40,873.50
May 20, 2022 IDA-D5950 Loan Disb 35,829.37
May 10, 2021 IDA-D5950 Loan Disb 412,500.00
Sep 6, 2021 IDA-65910 Loan Disb -476,129.03
Sep 6, 2021 IDA-D5950 Loan Disb 476,129.03
Jun 22, 2021 IDA-D5950 Loan Disb 5,386.77
Jun 22, 2021 IDA-D5950 Loan Disb -5,386.77
Aug 15, 2021 IDA-65910 Int Charges 3.41
Aug 15, 2021 IDA-65910 Int Charges 3.41
Aug 15, 2021 IDA-65910 Int Charges 1,796.32
Aug 15, 2021 IDA-65910 Int Charges 1,796.32
Feb 15, 2021 IDA-65910 Int Charges 1,798.42
Feb 15, 2021 IDA-65910 Int Charges 1,798.42
Jun 11, 2021 IDA-D5950 Loan Disb 44,094.51
Mar 22, 2023 IDA-65910 Loan Disb 11,885.10
Feb 15, 2023 IDA-65910 Int Charges 0.63
Feb 15, 2023 IDA-65910 Int Charges 0.63
Feb 15, 2023 IDA-65910 Int Charges 0.58
Feb 15, 2023 IDA-65910 Int Charges 0.58
May 17, 2023 IDA-65910 Loan Disb 462,199.00
Feb 15, 2023 IDA-65910 Int Charges 13.61
Feb 15, 2023 IDA-65910 Int Charges 13.61
Jan 18, 2022 IDA-D5950 Loan Disb 101,878.87
Jan 18, 2022 IDA-D5950 Loan Disb 3,162.49
Jan 18, 2022 IDA-D5950 Loan Disb 100,649.99
Jan 13, 2022 IDA-D5950 Loan Disb 54,173.90
Jan 13, 2022 IDA-D5950 Loan Disb 1,707.76
Dec 2, 2022 IDA-D5950 Loan Disb 10,000.00
Feb 15, 2022 IDA-65910 Int Charges 23.84
Feb 15, 2022 IDA-65910 Int Charges 23.84
Feb 15, 2022 IDA-65910 Int Charges 194.79
Feb 15, 2022 IDA-65910 Int Charges 194.79
May 25, 2022 IDA-D5950 Loan Disb 192,664.77
Jan 5, 2022 IDA-D5950 Loan Disb 95,375.25
Aug 15, 2023 IDA-65910 Int Charges 12.91
Aug 15, 2023 IDA-65910 Int Charges 12.91
Aug 15, 2023 IDA-65910 Int Charges 2,508.44
Aug 15, 2023 IDA-65910 Int Charges 2,508.44
Aug 15, 2023 IDA-65910 Int Charges 0.08
Aug 15, 2023 IDA-65910 Int Charges 0.08
Sep 27, 2023 IDA-65910 Loan Disb 334,665.00
Jun 2, 2023 IDA-65910 Loan Disb 520,788.00
Dec 23, 2022 IDA-D5950 Loan Disb -24,376.00
Mar 29, 2023 IDA-D5950 Loan Disb 186,199.90
Apr 12, 2023 IDA-65910 Loan Disb 325,654.00
Apr 2, 2020 IDA-65910 Loan Commitment 3,650,000.00
Apr 2, 2020 IDA-D5950 Loan Commitment 3,650,000.00
Aug 5, 2024 IDA-65910 Loan Disb -149,153.00
Jan 22, 2024 IDA-65910 Loan Disb 298,066.00
Feb 15, 2024 IDA-65910 Int Charges 5,951.94

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Procurement Moderately Satisfactory 2024-04-15
Financial Management Moderately Satisfactory 2024-04-15
Progress towards achievement of PDO Satisfactory 2024-04-15
Monitoring and Evaluation Satisfactory 2024-04-15
Overall Implementation Progress (IP) Moderately Satisfactory 2024-04-15
Project Management Moderately Satisfactory 2024-04-15

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • GOM has activated its public health National Emergency Operations Centre (NEOC) or a coordination mechanism for COVID-19ValueNoYesYes
    DateMarch 1, 2020December 29, 2023December 31, 2023
    Comment
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents per MOH guidelinesValue1.0035.005.00
    DateMarch 1, 2020December 29, 2023December 31, 2023
    Comment
  • GOM adopted personal and community non-pharmaceutical interventions (school closures, telework and remote meetings, reduce/cancel mass gatherings).ValueNoYesYes
    DateMarch 1, 2020December 29, 2023December 31, 2023
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Proportion of hospitals with adequate personal protective equipment within a given month.Value0.00100.0070.00
    DateMarch 1, 2020December 29, 2023December 31, 2023
    Comment
  • Number of regions with ICU capacityValue1.006.005.00
    DateMarch 1, 2020December 29, 2023December 31, 2023
    Comment
  • Proportion of hospitals who have submitted complete monthly reports on the number of suspected cases identified, number of cases tested, number of contacts traced, the presence of personal protectiveValue0.00100.0080.00
    DateMarch 1, 2020December 29, 2023December 31, 2023
    Comment
  • Proportion of health professionals trained in infection prevention and control per MOH-approved protocols.Value0.0080.0070.00
    DateMarch 1, 2020December 29, 2023December 31, 2023
    Comment
  • Percentage of received grievances that are resolvedValue0.007.6970.00
    DateAugust 9, 2021December 29, 2023December 29, 2023
    Comment
  • Number of designated laboratories with staff trained to conduct COVID-19 diagnosis.Value1.0035.005.00
    DateMarch 1, 2020December 29, 2023December 31, 2023
    Comment
  • Number of total daily testing capacity for SARS-CoV-2 in the country including five regional laboratoriesValue350.009000.001500.00
    DateMarch 22, 2020December 29, 2023December 31, 2023
    Comment
  • Average transport time for COVID-19 lab specimen from health facility to a regional testing centerValue30.004.0012.00
    DateJune 15, 2020December 29, 2023December 31, 2023
    Comment